Literature DB >> 15300321

[Neuroimaging in substance abuse disorders].

A de Mendelssohn1, S Kasper, J Tauscher.   

Abstract

The use of neuroimaging techniques in research on substance abuse disorders has advanced our understanding of the underlying pathophysiological and neuropsychological mechanisms. While initial structural imaging techniques were applied to investigate substance abuse-related cerebral atrophy, the functional techniques of SPECT, PET, and later fMRT and MRS provide a much broader range of possible research in this field. Besides their use in characterizing the pharmacology of abused substances and their relations to the pathophysiology of substance abuse disorders, they have also played an essential role in examining the neuropsychiatric underpinnings of the illness and their manifestation in changes of cerebral metabolism. Here, the influence of these techniques on the developing picture of substance abuse disorders is discussed by examining areas of particular scientific interest and reviewing exemplary findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300321     DOI: 10.1007/s00115-003-1565-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  102 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Evidence for a gender-related effect of alcoholism on brain volumes.

Authors:  D Hommer; R Momenan; E Kaiser; R Rawlings
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

3.  Functional magnetic resonance imaging of cocaine craving.

Authors:  B E Wexler; C H Gottschalk; R K Fulbright; I Prohovnik; C M Lacadie; B J Rounsaville; J C Gore
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

4.  Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; C Wong; J Logan
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

5.  Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: a stereological CT study.

Authors:  P Danos; D Van Roos; S Kasper; T Brömel; K Broich; C Krappel; L Solymosi; H J Möller
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

Review 6.  [Anhedonia--a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?].

Authors:  A Heinz
Journal:  Nervenarzt       Date:  1999-05       Impact factor: 1.214

7.  PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.

Authors:  T E Schlaepfer; G D Pearlson; D F Wong; S Marenco; R F Dannals
Journal:  Am J Psychiatry       Date:  1997-09       Impact factor: 18.112

8.  Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

Authors:  T P George; M C Chawarski; J Pakes; K M Carroll; T R Kosten; R S Schottenfeld
Journal:  Biol Psychiatry       Date:  2000-06-15       Impact factor: 13.382

9.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; J S Gatley; S Dewey; C Ashby; J Liebermann; R Hitzemann
Journal:  Arch Gen Psychiatry       Date:  1995-06
View more
  2 in total

Review 1.  [Cue-induced alcohol craving. Neurobiological correlates and clinical relevance].

Authors:  J Wrase; S M Grüsser; A Heinz
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

Review 2.  Identifying the neural circuitry of alcohol craving and relapse vulnerability.

Authors:  Andreas Heinz; Anne Beck; Sabine M Grüsser; Anthony A Grace; Jana Wrase
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.